Skip to content

inflammatory profile following nebulization of hypertonic saline as prophylaxis of VAP

Pro-inflammatory cytokine profile of intubated patients following nebulization of hypertonic saline as prophylaxis of VAP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201202169045N1
Enrollment
30
Registered
2015-09-01
Start date
2015-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilatory Associated Pneumonia. Aspiration pneumonia (due to): NOS, food, (regurgitated) gastric secretions, milk, vomit

Interventions

in intervention group 7 ml hypertonic saline 5% and in control group 7 ml sterile water will be nebulized each 6 hours until the extubated or maximum for 7 days. The patients will be followed for 28 d
Prevention

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: intubation period less than 24 hour, no clinical and imaging manifestation of pneumonia exclusion criteria: pulmonary infection; Acute physiology and chronic health evaluation II score II>25; active infection in admission; evidence of infection in chest X ray; immune deficiency; prescribe of high dose cortocosteroid (more than 300mg hydrocortisone); advanced cancer.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pneumonia. Timepoint: 0, 48, 72, 120 and 144 hour after start of study. Method of measurement: physical exam,chest x ray, culture of tracheal secretion.

Secondary

MeasureTime frame
Level of Interlukin- 6 levelof trachea secretions and blood. Timepoint: 0, 48,72,120 and 144 hour after start of study. Method of measurement: ELIZA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Taghi Beigmohammadi

Tehran University of Medical Sciences

beigmohammadi@tums.ac.ir - mbage46@gmail.com+98 21 6119 2511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026